Cellares Corp

Cellares is the pioneering Integrated Development and Manufacturing Organization (IDMO) dedicated to revolutionising cell therapy manufacturing through advanced automation and scalability.

Established with the mission to accelerate access to life-saving cell therapies, Cellares integrates cutting-edge technologies to mass-produce the living drugs of the 21st century. By adopting an Industry 4.0 approach, the company addresses the limitations of traditional contract development and manufacturing organisations (CDMOs), offering unparalleled scalability, cost efficiency, and quality in cell therapy production.

Key Products and Services

• Cell Shuttle™: A modular, cGMP-compliant platform designed for industrial-scale cell therapy manufacturing. This fully automated system can process up to 16 batches concurrently, significantly enhancing productivity and reducing manual labour requirements.

• Consumable Cartridge: A single-use, closed system that ensures end-to-end automation of the cell therapy manufacturing process, minimising contamination risks and streamlining operations.

• Cell Q™: An automated, high-throughput quality control platform tailored for cell therapies, ensuring consistent product quality and compliance with regulatory standards.

• Software Suite: A flexible and fully integrated software solution that facilitates process design, real-time monitoring, and seamless integration with third-party systems, enhancing operational efficiency.

• IDMO Services: Comprehensive services encompassing process development, optimisation, and automation, leveraging Cellares' proprietary technologies to expedite the journey from preclinical stages to commercialisation.

By harnessing advanced automation and a commitment to innovation, Cellares is poised to transform the landscape of cell therapy manufacturing. Their integrated approach not only reduces costs and enhances scalability but also ensures that life-saving treatments become more accessible to patients worldwide. As the demand for effective cell therapies continues to rise, Cellares stands at the forefront, delivering solutions that meet both current and future healthcare needs.